Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Jun;87(12):4702–4706. doi: 10.1073/pnas.87.12.4702

Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance.

M Skolovsky 1, R Galron 1, Y Kloog 1, A Bdolah 1, F E Indig 1, S Blumberg 1, G Fleminger 1
PMCID: PMC54185  PMID: 2191299

Abstract

Incubation of endothelins (ETs) with bovine kidney neutral endopeptidase (NEP) resulted in a selective two-step degradation with loss of biochemical activity. The Km of the enzyme indicated high-affinity binding, and hydrolysis was completely inhibited by phosphoramidon. The first step was nicking of the Ser5-Leu6 bond, followed by cleavage at the amino side of Ile19. The nicked peptide exhibited biochemical activities comparable to those of the intact peptide--i.e., binding to the ET receptor, induction of inositol phospholipid hydrolysis, and toxicity. The twice-cleaved product was inactive. The sarafotoxins (SRTXs) were more resistant than the ETs to NEP: for example, the half-time for ET-1 was approximately 1 hr, while it was approximately 4 hr for SRTX-b and even higher for SRTX-c. These in vitro findings may indicate a regulatory role of NEP (or similar enzymes) in the physiological inactivation of ETs. They might also help to explain why under certain physiological conditions ETs may be less toxic than SRTXs.

Full text

PDF
4702

Images in this article

4703Image
on p.4703
4703Image
on p.4703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambar I., Kloog Y., Kochva E., Wollberg Z., Bdolah A., Oron U., Sokolovsky M. Characterization and localization of a novel neuroreceptor for the peptide sarafotoxin. Biochem Biophys Res Commun. 1988 Dec 30;157(3):1104–1110. doi: 10.1016/s0006-291x(88)80987-2. [DOI] [PubMed] [Google Scholar]
  2. Ambar I., Kloog Y., Schvartz I., Hazum E., Sokolovsky M. Competitive interaction between endothelin and sarafotoxin: Binding and phosphoinositides hydrolysis in rat atria and brain. Biochem Biophys Res Commun. 1989 Jan 16;158(1):195–201. doi: 10.1016/s0006-291x(89)80197-4. [DOI] [PubMed] [Google Scholar]
  3. Bdolah A., Wollberg Z., Ambar I., Kloog Y., Sokolovsky M., Kochva E. Disturbances in the cardiovascular system caused by endothelin and sarafotoxin. Biochem Pharmacol. 1989 Oct 1;38(19):3145–3146. doi: 10.1016/0006-2952(89)90606-0. [DOI] [PubMed] [Google Scholar]
  4. Bdolah A., Wollberg Z., Fleminger G., Kochva E. SRTX-d, a new native peptide of the endothelin/sarafotoxin family. FEBS Lett. 1989 Oct 9;256(1-2):1–3. doi: 10.1016/0014-5793(89)81706-5. [DOI] [PubMed] [Google Scholar]
  5. Erdös E. G., Skidgel R. A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J. 1989 Feb;3(2):145–151. [PubMed] [Google Scholar]
  6. Fleminger G., Bousso-Mittler D., Bdolah A., Kloog Y., Sokolovsky M. Immunological and structural characterization of sarafotoxin/endothelin family of peptides. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1317–1323. doi: 10.1016/0006-291x(89)90817-6. [DOI] [PubMed] [Google Scholar]
  7. Galron R., Kloog Y., Bdolah A., Sokolovsky M. Functional endothelin/sarafotoxin receptors in rat heart myocytes: structure-activity relationships and receptor subtypes. Biochem Biophys Res Commun. 1989 Sep 15;163(2):936–943. doi: 10.1016/0006-291x(89)92312-7. [DOI] [PubMed] [Google Scholar]
  8. Hirata Y., Yoshimi H., Marumo F., Watanabe T. X., Kumagaye S., Nakajima K., Kimura T., Sakakibara S. Interaction of synthetic sarafotoxin with rat vascular endothelin receptors. Biochem Biophys Res Commun. 1989 Jul 14;162(1):441–447. doi: 10.1016/0006-291x(89)92017-2. [DOI] [PubMed] [Google Scholar]
  9. Indig F. E., Ben-Meir D., Spungin A., Blumberg S. Investigation of neutral endopeptidases (EC 3.4.24.11) and of neutral proteinases (EC 3.4.24.4) using a new sensitive two-stage enzymatic reaction. FEBS Lett. 1989 Sep 25;255(2):237–240. doi: 10.1016/0014-5793(89)81098-1. [DOI] [PubMed] [Google Scholar]
  10. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kimura S., Kasuya Y., Sawamura T., Shinmi O., Sugita Y., Yanagisawa M., Goto K., Masaki T. Structure-activity relationships of endothelin: importance of the C-terminal moiety. Biochem Biophys Res Commun. 1988 Nov 15;156(3):1182–1186. doi: 10.1016/s0006-291x(88)80757-5. [DOI] [PubMed] [Google Scholar]
  12. Kloog Y., Ambar I., Kochva E., Wollberg Z., Bdolah A., Sokolovsky M. Sarafotoxin receptors mediate phosphoinositide hydrolysis in various rat brain regions. FEBS Lett. 1989 Jan 2;242(2):387–390. doi: 10.1016/0014-5793(89)80507-1. [DOI] [PubMed] [Google Scholar]
  13. Kloog Y., Ambar I., Sokolovsky M., Kochva E., Wollberg Z., Bdolah A. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science. 1988 Oct 14;242(4876):268–270. doi: 10.1126/science.2845579. [DOI] [PubMed] [Google Scholar]
  14. Kloog Y., Bousso-Mittler D., Bdolah A., Sokolovsky M. Three apparent receptor subtypes for the endothelin/sarafotoxin family. FEBS Lett. 1989 Aug 14;253(1-2):199–202. doi: 10.1016/0014-5793(89)80958-5. [DOI] [PubMed] [Google Scholar]
  15. Kloog Y., Sokolovsky M. Similarities in mode and sites of action of sarafotoxins and endothelins. Trends Pharmacol Sci. 1989 Jun;10(6):212–214. doi: 10.1016/0165-6147(89)90261-7. [DOI] [PubMed] [Google Scholar]
  16. Le Monnier de Gouville A. C., Lippton H. L., Cavero I., Summer W. R., Hyman A. L. Endothelin--a new family of endothelium-derived peptides with widespread biological properties. Life Sci. 1989;45(17):1499–1513. doi: 10.1016/0024-3205(89)90415-3. [DOI] [PubMed] [Google Scholar]
  17. Maggi C. A., Giuliani S., Patacchini R., Santicioli P., Rovero P., Giachetti A., Meli A. The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors. Eur J Pharmacol. 1989 Jul 4;166(1):121–122. doi: 10.1016/0014-2999(89)90693-6. [DOI] [PubMed] [Google Scholar]
  18. Nakajima K., Kubo S., Kumagaye S., Nishio H., Tsunemi M., Inui T., Kuroda H., Chino N., Watanabe T. X., Kimura T. Structure-activity relationship of endothelin: importance of charged groups. Biochem Biophys Res Commun. 1989 Aug 30;163(1):424–429. doi: 10.1016/0006-291x(89)92153-0. [DOI] [PubMed] [Google Scholar]
  19. Randall M. D., Douglas S. A., Hiley C. R. Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat. Br J Pharmacol. 1989 Oct;98(2):685–699. doi: 10.1111/j.1476-5381.1989.tb12644.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Saida K., Mitsui Y., Ishida N. A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression, and biological activity. J Biol Chem. 1989 Sep 5;264(25):14613–14616. [PubMed] [Google Scholar]
  21. Saudek V., Hoflack J., Pelton J. T. 1H-NMR study of endothelin, sequence-specific assignment of the spectrum and a solution structure. FEBS Lett. 1989 Oct 23;257(1):145–148. doi: 10.1016/0014-5793(89)81807-1. [DOI] [PubMed] [Google Scholar]
  22. Warner T. D., de Nucci G., Vane J. R. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol. 1989 Jan 17;159(3):325–326. doi: 10.1016/0014-2999(89)90167-2. [DOI] [PubMed] [Google Scholar]
  23. Wollberg Z., Bdolah A., Kochva E. Vasoconstrictor effects of sarafotoxins in rabbit aorta: structure-function relationships. Biochem Biophys Res Commun. 1989 Jul 14;162(1):371–376. doi: 10.1016/0006-291x(89)92006-8. [DOI] [PubMed] [Google Scholar]
  24. Yanagisawa M., Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989 Sep;10(9):374–378. doi: 10.1016/0165-6147(89)90011-4. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES